Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.

V, Piechotta; KL, Chai; SJ, Valk; C, Doree; I, Monsef; EM, Wood; A, Lamikanra; C, Kimber; Z, McQuilten; C, So-Osman; LJ, Estcourt; N, Skoetz

doi:10.1002/14651858.cd013600.pub2

Public

Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.

Shared by NobleBlocks on Jul 10, 2020 • 12:00 AM UTC

Authors:

Piechotta V

Chai KL

Valk SJ

Abstract

Background Convalescent plasma and hyperimmune immunoglobulin may reduce mortality in patients with viral respiratory diseases, and are currently being investigated in trials as potential therapy for coronavirus disease 2019 (COVID-19). A thorough understanding of the current body of evidence regard...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!